C&L: Lief named chairman at Adventrx

Adventrx Pharmaceuticals announced that Jack Lief, president and CEO, and a founder and director of Arena Pharmaceuticals, was named chairman of Adventrx.

Raymond Tesi, M.D., F.A.C.S. has joined Coronado Biosciences as its president and CEO.

Par Pharmaceutical announced that Gerard A. Martino has been named executive vice president and COO and that Veronica A. Lubatkin has been named executive vice president and CFO.

Zogenix has named David Nassif executive vice president and CFO.

Pharmatech Associates has named Warford S. Reaney as executive vice president, consulting and international operations.

Achillion Pharmaceuticals announced that Milind Deshpande, Ph.D. has been promoted to executive vice president of research.

Alpharma has appointed Thomas J. Spellman III as its executive vice president, chief legal officer and corporate secretary.

Northfield Laboratories announced today that Richard D. Newman, Ph.D., D.A.B.T., will assume a leadership role for regulatory affairs. Eva Essig, Ph.D., who previously served in this role, has accepted a regulatory position in the pharmaceutical industry.

Cytogen has appointed Stephen A. Ross to the newly created position of senior vice president, sales and marketing.

Iroko Pharmaceuticals has named Dr. Susan Langer as chief medical officer and vice president of research & development.

Acusphere has appointed Patrick Gallagher as senior vice president, business development.

PDI has appointed Nancy Connelly as senior vice president, sales support services.

Inspire Pharmaceuticals has named Stephen Celestini as its chief compliance officer.

Progen Pharmaceuticals has named Dr. James Garner as vice president of medical and clinical affairs, and Dr. John Devlin as vice president of manufacturing operations.

Avexa has named Dr John Sime as a non-executive director of the company.

Antigenics has appointed John Hatsopoulos to its board of directors.

Anesiva announced today that James A. Harper, retired group vice president, global marketing and sales with Eli Lilly, has been elected to its board of directors.

Bionovo has named Richard Juelis to the company's board of directors. 

Nventa Biopharmaceuticals has named Sandford D. Smith to its board of directors.

Metabasis Therapeutics has elected Dr. George F. Schreiner, CEO of Raven Biotechnologies, to its board.

Frank Carlucci, former US Defense Secretary, will be heading Pluristem Life System's Strategic Business Advisory Board.

MIV Therapeutics announced that Dr. Greg L. Kaluza, M.D., Ph.D, has joined the company's Scientific Advisory Board.

VIVUS has appointed Dr. David Allison, Dr. Nancy Bohannon, Dr. Arthur Frank, Dr. Donna Ryan, Dr. Xavier Pi-Sunyer and Dr. Tom Wadden to the Qnexa SAB.

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.